Abstract
Background: Full-thickness macular holes (FTMH) are an important cause of visual loss in older patients. Recognition of tangential vitreofoveal traction as the mechanism of hole formation has led to the use of vitrectomy and gas tamponade as a treatment for macular holes. The use of growth factors as an adjunctive therapy to promote chorioretinal adhesion and hole closure has also been advocated.
Methods: Forty-four consecutive patients undergoing vitrectomy, posterior hyaloid removal, gas injection and installation of autologous serum for FTMH were studied prospectively. Patients' age, sex, duration of symptoms, best corrected pre- and post-operative Snellen visual acuities, best corrected acuity in the fellow eye, stage of macular hole, post-operative closure or persistence of the macular hole, and intra-and post-operative complications were recorded.
Results: Of 43 patients with adequate follow-up (minimum 6 weeks, mean 6.1 months) anatomical closure of the macular hole was achieved in 29 eyes (67%). The average visual improvement in these eyes was 2.7 lines. Twenty eyes (69%) with closed holes had visual acuity of 6/12 or better (47% of all patients undergoing surgery). Of the 14 eyes (33%) that failed, the average loss of vision was 0.4 lines and all these eyes had vision of 6/36 or worse.
Conclusions: In this series, surgical treatment of FTMH with vitrectomy, gas injection and autologous serum resulted in closure of the macular hole in two-thirds of patients and restored central vision in about one-half of patients. These results compare favourably with previously reported results of macular hole surgery. The answer to the question whether the use of autologous serum leads to a higher closure rate than surgery with gas tamponade alone requires information from randomised treatment trials, one of which is currently in progress.
Similar content being viewed by others
Article PDF
References
Gass JDM . Idiopathic senile macular hole: its early stages and pathogenesis. Arch Ophthalmol 1988;106:629–39.
Johnson RN, Gass JDM . Idiopathic senile macular holes: observations, stages of formation, and implications for surgical intervention. Ophthalmology 1988;95:917–24.
Guyer DR, de Bustros S, Diener-West M, Fine SL . Observations on patients with idiopathic macular holes and cysts. Arch Ophthalmol 1992;110:1264–8.
Smith RG, Hardman Lea SJ, Galloway NR . Visual performance in idiopathic macular holes. Eye 1990;4:190–4.
Acosta F, Lashkari K, Reynaud X, Jalkh AE, van de Velde F, Chedid N . Characterization of functional changes in macular holes and cysts. Ophthalmology 1991;98:1820–3.
Kelly NE, Wendel RT . Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol 1991;109:654–9.
Glaser BM, Michels RG, Kupperman BD, Sjaarda RN, Pena RA . Transforming growth factor-ß2 for the treatment of full thickness macular holes: a prospective randomized study. Ophthalmology 1992;99:1162–73.
Christmas NJ, Skolik SA, Howard MA, Saito Y, Barnstable CJ, Liggett PE . Treatment of retinal breaks with autologous serum in an experimental model. Ophthalmology 1995;102:263–71.
Watzke RC, Allen L . Subjective slit-beam sign for macular disease. Am J Ophthalmol 1969;68:449–53.
de Bustros S, and The Vitrectomy for Prevention of Macular Hole Study Group. Vitrectomy for prevention of macular hole: results of a randomized multicenter clinical trial. Ophthalmology 1994;101:1055–60.
Wendel RT, Patel AC, Kelly NE, Salzano TC, Wells JW, Novack GD . Vitreous surgery for macular holes. Ophthalmology 1993;100:1671–6.
Smiddy WE, Glaser BM, Green WR, Connor TB, Roberts AB, Lucas R, Sporn MB . Transforming growth factors beta: a biologic chorioretinal glue. Arch Ophthalmol 1989;107:577–80.
Liggett PE, Skolok SA, Hario B, Saito Y, Alfaro V, Mieler W . Human autologous serum for the treatment of full-thickness macular holes: a preliminary study. Ophthalmology 1995;102:1071–6.
Guyer DR, Green WR, de Bustros S, Fine SL . Histopathologic features of idiopathic macular holes and cysts. Ophthalmology 1990;97:1045–51.
Funata M, Wendel RT, De La Cruz Z, Green WR . Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina 1992;12:289–98.
Madreperla SA, Geiger GL, Funata M, de la Cruz Z, Green WR . Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology 1994;101:682–6.
Fine SL . Vitreous surgery for macular hole in perspective: is there an indication? Arch Ophthalmol 1991;109:635–6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wells, J., Gregor, Z. Surgical treatment of full-thickness macular holes using autologous serum. Eye 10, 593–599 (1996). https://doi.org/10.1038/eye.1996.136
Issue Date:
DOI: https://doi.org/10.1038/eye.1996.136
Keywords
This article is cited by
-
Platelet concentrates in macular hole surgery. A journey through the labyrinth of terminology, preparation, and application: a comprehensive review
Graefe's Archive for Clinical and Experimental Ophthalmology (2024)
-
Combination of Inverted ILM Flap Technique and Subretinal Fluid Application Technique for Treatment of Chronic, Persistent and Large Macular Holes
Ophthalmology and Therapy (2021)
-
Pedicle internal limiting membrane flap technique for very large macular holes: a preliminary report
International Journal of Retina and Vitreous (2020)
-
Effects of mesenchymal stem cells and their exosomes on the healing of large and refractory macular holes
Graefe's Archive for Clinical and Experimental Ophthalmology (2018)
-
Equivalent tamponade by room air as compared with SF6 after macular hole surgery
Graefe's Archive for Clinical and Experimental Ophthalmology (2009)